Skip to Main Content

Paper Details

High effector-memory CD8<sup>+</sup> T-cell levels correlate with high PML risk in natalizumab-treated patients.
Mult Scler Relat Disord
1
2020
Author NameAffiliation
Matthieu DuchmannHenri Mondor University Hospital
  • 1 - 1

Datasets

Release 1.2